EMA — authorised 30 July 2009
- Marketing authorisation holder: Sanofi B.V.
- Status: approved
EMA authorised Mozobil on 30 July 2009
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 30 July 2009.
Sanofi B.V. holds the EU marketing authorisation.